You searched for Adrian Towse - Page 4 of 17

We found for

Transferability of HTA

HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?

How can HTA meet the needs of health system and government decision makers?

Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies

Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

Policy Options for Formulary Development in Middle-income Countries

Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study

Uncertainty and Risk in HTA Decision Making

Improving Efficiency and Resource Allocation in Future Cancer Care

Four Case Studies to Explore the Added Value of Oxford AHSN

How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?

Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making

Data Governance Arrangements for Real-World Evidence

Multi-indication Pricing: Pros, Cons and Applicability to the UK

International Decision Support Initiative (iDSI): Mapping of priority-setting in health in 17 low and middle countries across Asia, Latin America, and Africa

01
02
03
04
05
06
07

Latest Research & Publications

All Publications

We found for

Filter results by

Transferability of HTA

HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?

How can HTA meet the needs of health system and government decision makers?

Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies

Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

Policy Options for Formulary Development in Middle-income Countries

Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study

Uncertainty and Risk in HTA Decision Making

Improving Efficiency and Resource Allocation in Future Cancer Care

Four Case Studies to Explore the Added Value of Oxford AHSN

How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?

Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making

Data Governance Arrangements for Real-World Evidence

Multi-indication Pricing: Pros, Cons and Applicability to the UK

International Decision Support Initiative (iDSI): Mapping of priority-setting in health in 17 low and middle countries across Asia, Latin America, and Africa